OSIVAX
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS
BOARD OF DIRECTORS
Picture

​


Dr Hugues WALLEMACQ, DVM
Member of the Board of Directors

Noshaq Investment Manager
​

Hugues has a broad experience in medical field ranging from research and ​development to commercialization ​of innovative vaccines and diagnostic applications. He is an experienced in biotech, pharmaceutical and innovation.

Prior experience:
  • Investment Manager, Noshaq (2020)
  • Director of R&D Department, Unisensor (2017-2019)
  • Director of Clinical Immuno-Assays Platform, GSK Vaccines (2014-2016)
  • Preclinical Vaccine Leader, GSK Vaccines (2010-2013)
  • PhD in Immunology, GIGA, Belgium (2007-2010)
  • Veterinary Practice, France (2003-2006)
  • Doctor in Veterinary Medicine, Belgium (1998-2003)

Education:
  • 2019 -2021 MBA- Business Schools of Maastricht University, Netherlands
  • Faculty of Veterinary Medicine (FMV), Liège, Belgium
return
Proudly powered by Weebly
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS